While these candidates outline a rich regulatory network linking T-cadherin to gastric and ovarian cancer, coronary artery disease, and endothelial and developmental pathways, definitive binding assays and functional studies are warranted to move them from bioinformatically predicted interactions to biological facts. This evidence concerns the gene CDH13 and ovarian carcinoma.